300194.SZ · 福安药业
China A-shares · RS rating 82 · As of 2026-10-14
| Price | 3.94 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 80 / 77 / 56 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 32 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +6.0% |
| Distance from 52-week high | +17.2% |
| Market cap (USD) | $717.0M |